Prothea Technologies

Provider of lung cancer biopsy and treatments

placeEdinburgh, Scotland, United Kingdom calendar_todayFounded 2024 language prothea.tech

Registered entities

Social engagement

Social engagement: 696 social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Earlybird, Merieux Equity Partners.

Investor typeCountShare
Venture capital240%
Private equity240%
Other / undisclosed120%
Coming soon